As with Ozempic, youll likely start with a much more conservative dose and gradually ramp up
Compared to some other GLP-1 medications that may have been developed primarily for diabetes, the formulation of semaglutide for weight loss (Wegovy) is specifically dosed and studied for its effectiveness in helping people without diabetes manage a medical condition like obesity
In type 2 diabetes, the body's efficiency in using insulin is diminished, leading to elevated blood sugar levels, or hyperglycemia
Our comprehensive guide on semaglutide fatigue covers this in detail
Its FDA-approved for weight loss and still being studied for diabetes
Based on individual patient response and tolerability, the dose may be further titrated in 2.5mg increments every four weeks, up to a maximum of 15mg per week